- Company Overview for YORKDALE PHARMA LIMITED (13473836)
- Filing history for YORKDALE PHARMA LIMITED (13473836)
- People for YORKDALE PHARMA LIMITED (13473836)
- Charges for YORKDALE PHARMA LIMITED (13473836)
- More for YORKDALE PHARMA LIMITED (13473836)
| Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
|---|---|---|---|
| 25 Nov 2021 | AP01 | Appointment of Steen Vangsgaard as a director on 22 November 2021 | |
| 25 Nov 2021 | PSC07 | Cessation of Rosemont Pharmaceuticals Limited as a person with significant control on 22 November 2021 | |
| 25 Nov 2021 | PSC02 | Notification of Cortex 3 Guernsey Limited as a person with significant control on 22 November 2021 | |
| 25 Nov 2021 | PSC01 |
Notification of Guy Semmens as a person with significant control on 22 November 2021
|
|
| 02 Jul 2021 | CH01 | Director's details changed for Mr Howard Langton Taylor on 23 June 2021 | |
| 23 Jun 2021 | NEWINC |
Incorporation
Statement of capital on 2021-06-23
|